Elevated Paracellular Glucose Flux across Cystic Fibrosis Airway Epithelial Monolayers Is an Important Factor for Pseudomonas aeruginosa Growth. by Garnett, JP et al.
Elevated Paracellular Glucose Flux across Cystic Fibrosis
Airway Epithelial Monolayers Is an Important Factor for
Pseudomonas aeruginosa Growth
James P. Garnett1*, Michael A. Gray2, Robert Tarran3, Malcolm Brodlie4, Christopher Ward4,
Emma H. Baker1, Deborah L. Baines1
1Division of Biomedical Sciences, St George’s University of London, London, United Kingdom, 2 Institute for Cell and Molecular Biosciences, Newcastle University,
Newcastle-upon-Tyne, United Kingdom, 3Cystic Fibrosis/Pulmonary Research and Treatment Centre, University of North Carolina, Chapel Hill, North Carolina, United
States of America, 4 Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom
Abstract
People with cystic fibrosis (CF) who develop related diabetes (CFRD) have accelerated pulmonary decline, increased
infection with antibiotic-resistant Pseudomonas aeruginosa and increased pulmonary exacerbations. We have previously
shown that glucose concentrations are elevated in airway surface liquid (ASL) of people with CF, particularly in those with
CFRD. We therefore explored the hypotheses that glucose homeostasis is altered in CF airway epithelia and that elevation of
glucose flux into ASL drives increased bacterial growth, with an effect over and above other cystic fibrosis transmembrane
conductance regulator (CFTR)-related ASL abnormalities. The aim of this study was to compare the mechanisms governing
airway glucose homeostasis in CF and non-CF primary human bronchial epithelial (HBE) monolayers, under normal
conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM
or 15 mM basolateral glucose to investigate how changes in blood glucose, such as those seen in CFRD, affects luminal Ps.
aeruginosa growth. Calu-3 cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa
growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired CFTR-dependent fluid
secretions. We show that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway
epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions elicited more glucose flux across CF airway
epithelial monolayers compared to non-CF monolayers which we propose increases glucose availability in ASL for bacterial
growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above any CFTR-dependent
effects and the presence or absence of mucus in Calu-3 airway epithelia-bacteria co-cultures. Together these studies
highlight the importance of glucose as an additional factor in promoting Ps. aeruginosa growth and respiratory infection in
CF disease.
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Introduction
The airway epithelium is covered by a thin layer of surface
liquid (ASL), which is vital for maintaining a healthy respiratory
tract. It is now well established in cystic fibrosis (CF) that a lack of
functional cystic fibrosis transmembrane conductance regulator
(CFTR) impairs airway bicarbonate and fluid secretion producing
an acidic, viscous ASL [1,2,3] that is readily colonised by bacteria
such as Pseudomonas aeruginosa [4]. Much has been made of the
defective anti-microbial properties of the CF ASL and of changes
in host-pathogen responses across the CF airway epithelium.
However, relatively little has been reported on disease-related
changes in the nutritional content of ASL, such as elevated glucose
concentrations, that could stimulate bacterial growth in CF
airways.
In people with CF, coexisting diabetes mellitus (CF-related
diabetes; CFRD) is associated with an increased risk of infection
with multiple antibiotic-resistant Ps. aeruginosa. Patients with CFRD
have more pulmonary exacerbations, which are less likely to
respond to intravenous antibiotics, than those without diabetes [5].
We have previously shown that ASL glucose concentrations are
elevated in patients with CF (,2 mM; compared to ,0.4 mM in
healthy individuals) and are further elevated in CFRD to ,4 mM
[6]. In intubated patients on intensive care, we found that elevated
glucose concentrations in bronchial aspirates were associated with
the presence and acquisition of respiratory pathogens [7]. In mice,
glucose concentrations were elevated in lung secretions from
diabetic compared to wild-type animals and bacterial load was
greater in the airways of diabetic than wild-type mice [8,9]. In
human airway epithelial cells grown at air-liquid interface,
elevation of basolateral glucose concentrations increased ASL
glucose concentrations and directly promoted the growth of
respiratory pathogens such as Ps. aeruginosa [8].
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ASL glucose concentration is the net effect of the paracellular
diffusion of glucose from the blood/interstitial fluid across the
airway epithelium into ASL and its removal from ASL by
epithelial uptake through facilitative glucose transporters, GLUT2
and GLUT10 [9,10,11,12]. We have previously shown that
paracellular glucose diffusion is increased not only by elevating
basolateral glucose concentrations (e.g. hyperglycaemia), but also
by inflammation, which disrupts tight junction integrity. In human
epithelial cell monolayers, we found that application of either
apical pro-inflammatory cytokines [10] or apical bacterial
pathogens [8] increased paracellular glucose flux, increasing
glucose concentrations in ASL. Under pro-inflammatory condi-
tions, airway epithelial glucose uptake through apical GLUTs is
elevated, but this is insufficient to compensate for the increased
paracellular glucose leak and does not prevent elevation of ASL
glucose concentrations [10]. Control of paracellular glucose
movement thus appears to be the main rate-limiting step for
maintaining low ASL glucose concentrations. Since the CF airway
epithelium is known to be more susceptible to inflammation-
induced changes in tight junctions and paracellular permeability
compared to non-CF epithelium [13], we hypothesised that this
may account for the elevation in ASL glucose concentrations
observed in CF patients without diabetes, which is augmented
further by hyperglycaemia in CFRD.
The aim of this study was to compare the mechanisms
governing airway glucose homeostasis in polarized monolayers of
CF and non-CF primary human bronchial epithelial (HBE) cells,
under normal conditions and in the presence of Ps. aeruginosa
filtrate. HBE-bacterial co-cultures were performed in the presence
of 5 mM or 15 mM basolateral glucose to investigate how changes
in glucose concentration, such as those seen in CFRD, affect apical
Ps. aeruginosa growth. In addition, Calu-3 human airway epithelial
cell monolayers were used to evaluate the potential importance of
glucose on Ps. aeruginosa growth, in comparison to other hallmarks
of the CF ASL, namely mucus hyperviscosity and impaired cystic
fibrosis transmembrane conductance regulator (CFTR)-dependent
fluid secretions.
Methods
Primary Human Bronchial Epithelial Cell Culture
Primary human bronchial epithelial (HBE) cells (non-CF and
CF) were obtained from endobronchial brushings or extracted
from explanted lungs and cultured as previously described
[14,15,16]. HBE cells were obtained in accordance with approval
from the relevant ethics committees and informed written consent
from all study patients: Newcastle and North Tyneside Local
Regional Ethics Committee (reference number 2001/179 and 07/
Q0906/47); The University of North Carolina at Chapel Hill
Biomedical Institutional Review Board (protocol #03-1396). Cells
were transferred onto clear Costar TranswellH inserts (0.45-mm
pore size) and grown at air-liquid-interface (ALI) to form confluent
monolayers. Cells were studied 3–5 weeks post-seeding.
Calu-3 Cell Culture
The human adenocarcinoma-derived cell line, Calu-3 (from
ATCC), was grown in Eagle’s minimal essential medium (EMEM)
plus 10% FCS, 2 mM L-glutamine, 100 units/ml penicillin,
100 mg/ml streptomycin, and 1% non-essential amino acids
(Sigma) and incubated in humidified air containing 5% CO2 at
37uC.
Calu-3 cells were seeded onto clear Costar TranswellH inserts
(0.45-mm pore size) at 250,000 cells/cm2 to form confluent
polarised monolayers, as previously described [17]. Experiments
were carried out 10–14 days post-seeding.
For studies examining the effect of a viscous mucus layer on
bacterial growth in co-culture, Calu-3 monolayers were grown at
ALI 5 days post-seeding on transwell supports. Under these
conditions a thick mucus layer builds up on the apical surface
which can be removed by washing the surface with PBS. 72 hours
before the experiment, transwells were washed to remove the
mucus layer and placed in Krebs salt solution consisting of
115 mM NaCl, 5 mM KCl, 25 mM NaHCO3, 1 mM MgCl2,
1 mM CaCl2 and 5 mM D-glucose (equilibrated with 5% CO2 to
pH 7.4) to remove antibiotics and components of the media that
could influence bacterial growth. The cells were incubated to allow
the mucus layer to re-form. The transwells were then divided into
two parallel sets. One set of transwells were re-washed to remove
this layer just prior to experimentation, while another set were
lightly washed to preserve the mucus layer.
Ps. aeruginosa Culture
Ps. aeruginosa strain PA01 was used for the experiments. A single
colony of PA01 was incubated overnight at 37uC in EMEM
(containing 5 mM glucose) to form a culture of approximately
56109 colony forming units (CFU)/ml.
Ps. aeruginosa filtrate was prepared by boiling (10 minutes),
centrifuging (5,5006G for 30 minutes) and then filtering (0.45 mm
pore filter) the overnight bacterial culture, as previously described
[18]. The filtrate was diluted 1:10 in glucose-free media prior to
addition to airway epithelial cell cultures. It has previously been
shown that 10% Ps. aeruginosa filtrate is not highly cytotoxic to
HBE cells over a similar time course [19].
Paracellular L-glucose flux and D-glucose uptake
experiments
Paracellular movement of glucose across HBE monolayers was
measured by analysis of radiolabelled [14C]-L-glucose transepi-
thelial flux. Experiments were initiated by adding 1 ml of Krebs
salt solution containing 1.0 mCi of [14C]-L-glucose plus 10 mM of
non-radiolabelled equivalent glucose to the basolateral side of the
transwells and 0.1 ml of glucose-free Krebs salt solution to the
apical side. Apical and basolateral samples were taken after 1 h
and the concentration of radiolabelled glucose was analysed using
a scintillation counter.
[14C]-D-glucose uptake experiments on HBE monolayers were
performed as previously described [10].
In vitro co-culture model
Bacterial cultures were diluted in glucose-free Krebs salt
solution (composition described above). 50 ml or 100 ml of
16107 CFU/ml PA01 was applied to the apical surface of HBE
or Calu-3 cell monolayers, respectively. The basolateral side of the
airway epithelial-bacterial co-cultures were washed and placed in
Krebs salt solution 24 hours prior to co-culture experiments to
remove antibiotics and components of the media that could
influence bacterial growth. Normal blood glucose or hyperglycae-
mia was modelled by applying basolateral glucose concentrations
of 5 and 15 mM, respectively. Co-cultures were placed in a CO2
incubator at 37uC for 7 hours, after which each was homogenised
and CFU calculated by plating out serial dilutions.
ASL glucose
To evaluate the effects of Ps. aeruginosa and/or basolateral
glucose on the glucose concentration of the ASL overlying Calu-3
monolayers, the apical surface was washed and then 100 ml of
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glucose-free Krebs salt solution was placed onto the surface of
monolayers with or without Ps. aeruginosa filtrate. The basolateral
side was supplied with Krebs salt solution containing either 5 or
15 mM D-glucose. Cultures were left for 24 hours to equilibrate.
Apical fluid was subsequently removed from the cell surface and
glucose concentrations were measured using a glucose oxidase
analyser (Analox Instruments, UK).
Transepithelial Liquid Secretion
The rate and pH of liquid secreted from Calu-3 monolayers was
measured as previously described [17], after 7 hours of co-culture
with PA01.
Chemicals and reagents
All chemicals and reagents were obtained from Sigma, Poole,
UK unless otherwise stated.
Statistical analysis
Values are reported as mean 6 S.E.M. Statistical analysis was
performed using analysis of variance (ANOVA) and post hoc
Bonferroni multiple comparison or Student’s t test. P values ,0.05
were considered significant.
Results
CF airway epithelial monolayers exhibit similar rates of
glucose uptake to non-CF monolayers
Comparison of 14C-D-glucose uptake rates by non-CF and CF
human bronchial epithelial (HBE) monolayers showed no
significant difference in either apical or basolateral uptake
(Figure 1). Apical glucose uptake was 1.160.1 nmol/cm2/min
and 1.060.1 nmol/cm2/min across non-CF and CF HBE
monolayers, respectively (p.0.05, n = 3; Figure 1A). Basolateral
glucose was significantly higher than apical uptake in both cell
types: 3.660.2 nmol/cm2/min and 2.960.3 nmol/cm2/min
across non-CF and CF HBE monolayers, respectively (n = 3;
Figure 1B).
Ps. aeruginosa filtrate increases apical glucose uptake
across human airway epithelial monolayers
The addition of Ps. aeruginosa filtrate to the apical surface (for
24 hours) led to an increase in apical, but not basolateral, D-
glucose uptake by non-CF (58612% increase; p,0.05, n= 3;
Figure 1A) and CF (78614%; p,0.05, n= 3) HBE monolayers.
No significant difference in Ps. aeruginosa-induced glucose uptake
was observed between non-CF and CF HBE monolayers (p.0.05,
n = 3).
Ps. aeruginosa filtrate reduces transepithelial resistance
and enhances paracellular glucose flux across CF
epithelium to a greater extent than non-CF epithelium
Comparison of the transepithelial resistance (RT; Figure 2A)
and the paracellular basolateral-to-apical flux of L-glucose
(Figure 2B) across non-CF and CF HBE monolayers showed no
significant difference between the cell types under control
conditions (p.0.05, n= 3). However, addition of the bacterial
filtrate to the apical surface of HBE monolayers (for 24 hours)
produced a significant reduction in RT and a corresponding
increase in the paracellular flux of glucose. Ps. aeruginosa filtrate
induced a significantly larger decrease in RT across CF HBE
monolayers (778641 V.cm2 to 381656 V.cm2; p,0.05, n= 6;
Figure 2A) compared to non-CF HBE monolayers (737655
V.cm2 to 544642 V.cm2; p,0.001, n= 6). Similarly, the Ps.
aeruginosa-induced increase in paracellular L-glucose flux was much
greater across CF HBE monolayers (164619%; p,0.01, n= 4;
Figure 2C) compared to non-CF HBE monolayers (65610%,
p,0.05, n = 4).
Elevating basolateral D-glucose concentration increases
the growth of apical Ps. aeruginosa across airway
epithelial monolayers
Ps. aeruginosa was added to the apical surface of non-CF HBE
monolayers for 7 hours in the presence of 5 mM or 15 mM
basolateral D-glucose. Increasing the basolateral concentration of
D-glucose from 5 to 15 mM resulted in a 69613% increase in
apical Ps. aeruginosa growth (p,0.05, n = 4; Figure 3A). Increasing
the L-glucose, rather than D-glucose, concentration in the
basolateral solution did not enhance apical bacterial growth.
Basolateral glucose-induced growth of apical Ps.
aeruginosa is greater across CF airway epithelial
monolayers
Interestingly, although elevation of basolateral glucose from 5 to
15 mM enhanced apical bacterial growth across both non-CF and
CF HBE monolayers, the glucose-induced increase in Ps. aeruginosa
Figure 1. Ps. aeruginosa filtrate increases apical glucose uptake
across non-CF and CF human airway epithelial monolayers.
Glucose (14C-D-glucose) uptake across the apical (A) and basolateral (B)
membrane of non-CF and CF HBE monolayers, in the presence and
absence of Ps. aeruginosa filtrate (Ps. a). n = 3 in each group, obtained
using cells from 3 different non-CF and CF donors assayed in 3 separate
experiments. * p,0.05.
doi:10.1371/journal.pone.0076283.g001
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growth was greater across CF HBE monolayers (p,0.05, n= 4;
Figure 3B). Raising basolateral glucose increased the apical
concentration of Ps. aeruginosa from 5.861.0 CFU (x107)/ml to
10.561.4 CFU (6107)/ml and from 11.361.3 CFU (x107)/ml to
26.865.2 CFU (x107)/ml, on non-CF and CF HBE monolayers,
respectively.
Apical Ps. aeruginosa addition increases glucose flux
across Calu-3 airway epithelial monolayers, resulting in
elevated ASL glucose and D-glucose dependent bacterial
growth
The addition of Ps. aeruginosa to the apical surface of Calu-3
monolayers for 7 hours increased basolateral-to-apical L-glucose
flux across the monolayers in a dose-dependent manner (p,0.001,
n = 3; Figure 4A). To investigate whether increased flux resulted in
elevated glucose in the ASL, Ps. aeruginosa filtrate was used to
eliminate the possibility of bacterial glucose uptake affecting ASL
concentration. Ps. aeruginosa filtrate increased the concentration of
glucose present in the ASL from 0.660.1 mM to 1.160.1 mM
(p,0.05, n= 3; Figure 4B). Increasing the basolateral concentra-
tion of D-glucose from 5 to 15 mM further increased ASL glucose
concentrations from 1.160.1 mM to 5.860.8 mM (p,0.001,
n = 3). When the growth of Ps. aeruginosa applied to the apical
surface of Calu-3 monolayers was measured after 7 hours,
increasing the basolateral concentration of D-glucose, but not L-
glucose, resulted in an increase in growth from 4.761.0 CFU
(x107)/ml to 9.160.7 CFU (6107)/ml (an increase of 94619%;
p,0.01, n= 6; Figure 4C), consistent with our observations in
non-CF and CF HBE cells.
Increasing basolateral glucose enhances apical Ps.
aeruginosa growth on Calu-3 monolayers over and above
the effects of CFTR-dependent secretions and mucus
hyperviscosity
In order to gauge the potential importance of glucose-induced
changes in bacterial growth in comparison to other hallmark
abnormalities of the CF ASL, co-cultures were performed on
Calu-3 airway epithelial cells. Calu-3 cultures are heterogeneous,
consisting of both serous (fluid-secreting) and mucous (mucin-
secreting) cell types, which produce CFTR-dependent secretions.
Figure 2. Ps. aeruginosa filtrate reduces transepithelial resistance and enhances paracellular glucose flux across CF epithelium to a
greater extent than non-CF epithelium. A: Transepithelial resistance (RT) across non-CF and CF HBE monolayers, in the presence and absence of
Ps. aeruginosa filtrate (Ps. a). n = 6 in each group, obtained using cells from 3 different non-CF and CF donors assayed in 2 separate experiments. *
p,0.05, *** p,0.001. B: Basolateral-to-apical paracellular L-glucose (14C-L-glucose) flux across untreated non-CF and CF HBE monolayers. n = 4 in
each group, obtained using cells from 2 different non-CF and CF donors assayed across 4 separate experiments. C: Basolateral-to-apical paracellular L-
glucose (14C-L-glucose) flux across non-CF and CF HBE monolayers in the presence of Ps. aeruginosa filtrate (Ps. a). n = 4 in each group, obtained using
cells from 2 different non-CF and CF donors assayed across 4 separate experiments. ** p,0.01.
doi:10.1371/journal.pone.0076283.g002
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Addition of the cAMP-agonist forskolin, which stimulates
CFTR-dependent fluid secretion from these cells [17], significantly
reduced Ps. aeruginosa growth by 6368% (in the presence of 5 mM
basolateral glucose; p,0.001, n= 6; Figure 5A). However, Ps.
aeruginosa growth remained higher in 15 mM glucose compared to
5 mM during forskolin stimulation (4.660.5 CFU (6107)/ml in
15 mM glucose, compared to 1.760.2 CFU (6107)/ml in 5 mM
glucose; p,0.05, n = 6; Figure 5A). Forskolin-stimulated co-
cultures increased the apical fluid volume by 761 ml after 7 hours
(p,0.05, n = 6; Figure 5B) and the pH of the apical fluid increased
from 7.4360.02 to 7.5160.03 pH units (p,0.05, n= 4;
Figure 5C). The forskolin-mediated inhibition of Ps. aeruginosa
growth could be partially overcome by the CFTR pore blocker
GlyH-101 (p,0.05, n= 6; Figure 5A). However, the CFTR
blocker had no effect on the 15 mM glucose-induced increase in
Ps. aeruginosa growth. Although inhibiting CFTR abolished the
forskolin-stimulated increase in apical fluid volume (p,0.05, n= 6;
Figure 5B), it had no effect on the forskolin-induced alkalinisation
(p.0.05, n = 4; Figure 5C). These data indicate that CFTR ion
conductance is important for ASL antimicrobial activity but that
Figure 3. Basolateral glucose-induced growth of apical Ps.
aeruginosa is greater across CF airway epithelial monolayers. A:
Ps. aeruginosa growth over 7 hours across the apical surface of HBE
monolayers, in the presence of 5 mM D-glucose, 15 mM basolateral D-
glucose or 5 mM D-glucose plus 10 mM L-glucose. n = 4 in each group,
obtained using cells from 2 different non-CF and CF donors assayed
across 4 separate experiments. * p,0.05. B: Ps. aeruginosa growth over
7 hours across the apical surface of non-CF and CF HBE monolayers, in
the presence of 5 mM or 15 mM basolateral D-glucose. n = 4 in each
group, obtained using cells from 2 different non-CF and CF donors
assayed across 4 separate experiments. * p,0.05.
doi:10.1371/journal.pone.0076283.g003
Figure 4. Apical Ps. aeruginosa addition increases glucose flux
across Calu-3 airway epithelial monolayers, resulting in
elevated ASL glucose and D-glucose dependent bacterial
growth. A: Basolateral-to-apical paracellular L-glucose (14C-L-glucose)
flux across untreated Calu-3 monolayers and monolayers pre-exposed
to Ps. aeruginosa (16106, 16107 or 16108 CFU) for 7 hours. n = 3 in
each group, obtained from 3 independent experiments. ** p,0.01, ***
p,0.001. B: Glucose concentration of airway surface liquid (ASL) across
Calu-3 airway epithelial monolayers after 24 hours, in the presence of 5
or 15 mM basolateral glucose, with or without Ps. aeruginosa filtrate (Ps.
a). n = 3 in each group, obtained from 3 independent experiments. *
p,0.05, *** p,0.001. C: Ps. aeruginosa growth over 7 hours across the
apical surface of Calu-3 monolayers, in the presence of 5 mM D-glucose,
15 mM basolateral D-glucose or 5 mM D-glucose plus 10 mM L-
glucose. n = 6 in each group, obtained from 3 independent exper-
iments. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0076283.g004
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elevation of basolateral glucose from 5 to 15 mM promotes Ps.
aeruginosa growth irrespective of CFTR activity.
Calu-3 monolayers grown at ALI generate a thick layer of
mucus on the apical surface over time. The presence of this mucus
layer increased Ps. aeruginosa CFU by 5767%, compared to
monolayers in which the mucus layer had been removed (in the
presence of 5 mM basolateral glucose; p,0.05, n= 4; Figure 6).
Importantly, elevating basolateral glucose increased Ps. aeruginosa
CFU in the presence or absence of mucus (p,0.05, n= 4;
Figure 6).
Basolateral glucose alters airway epithelial monolayer
transepithelial resistance
Interestingly, we found that elevating the basolateral glucose
concentration reduced transepithelial resistance (RT). Increasing
basolateral glucose from 5 to 15 mM decreased Calu-3 monolayer
RT from 11606115 V.cm
2 to 816683 V.cm2 (p,0.05, n= 6;
Figure 7). A similar glucose-induced decrease in Calu-3 RT was
also observed after 7 hours of co-culture with 16106 CFU/cm2
Ps. aeruginosa, although this effect is likely to be, at least in part, due
to the elevated growth of the bacteria in the presence of increased
basolateral glucose. At higher bacteria inoculations, no significant
difference in Calu-3 RT was observed between glucose concen-
trations (p.0.05, n = 6).
Discussion
We have previously shown that ASL glucose concentrations are
elevated in people with chronic lung inflammation, including those
with CF [6,20]. ASL glucose concentrations are also increased by
hyperglycaemia [6]. Diabetes mellitus is a common comorbidity
with CF and the combination of lung inflammation and
hyperglycaemia produces a further increase in ASL glucose
concentrations [6].
Figure 5. Increasing basolateral glucose enhances apical Ps.
aeruginosa growth across Calu-3 monolayers over and above
the effects of CFTR-dependent secretions. A: Ps. aeruginosa
growth over 7 hours across the apical surface of untreated or forskolin-
stimulated Calu-3 monolayers (6CFTR pore blocker GlyH-101), in the
presence of 5 mM or 15 mM basolateral D-glucose. n = 6 in each group,
obtained from 3 independent experiments. * p,0.05, *** p,0.001. B:
Changes in the apical fluid volume ( ml) of Ps. aeruginosa-Calu-3 co-
cultures over 7 hours (starting volume = 100 ml). n = 6 in each group,
obtained from 3 independent experiments. * p,0.05. C: Changes in the
pH of apical fluid from Ps. aeruginosa-Calu-3 co-cultures over 7 hours.
n = 6 in each group, obtained from 3 independent experiments. *
p,0.05.
doi:10.1371/journal.pone.0076283.g005
Figure 6. Increasing basolateral glucose enhances apical Ps.
aeruginosa growth across Calu-3 monolayers over and above
the effects of mucus hyperviscosity. Ps. aeruginosa growth over
7 hours across the apical surface of Calu-3 monolayers with or without a
viscous mucus layer, in the presence of 5 mM or 15 mM basolateral D-
glucose. n = 4 in each group, obtained from 4 independent exper-
iments. * p,0.05.
doi:10.1371/journal.pone.0076283.g006
Glucose & Bacterial Growth on CF Airway Epithelium
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Elevated ASL glucose concentrations are associated with an
increased risk of respiratory infection and diabetes is a predispos-
ing factor for acquisition of multiple antibiotic resistant Ps.
aeruginosa and increased pulmonary exacerbations in people with
CF [5]. The aims of this study were to use human airway epithelial
cell culture models to explore mechanisms underlying the
relationship between changes in ASL glucose and increased
susceptibility to infection in CF.
We found that exposure to Ps. aeruginosa filtrate or live Ps.
aeruginosa, decreased transepithelial resistance (RT) and increased
paracellular glucose flux across human airway epithelial mono-
layers, consistent with our previous observations [8]. Ps. aeruginosa,
in addition to cell-associated virulence factors such as LPS, pili and
flagella, which can activate inflammatory responses via toll-like
receptors (TLRs) [21], secrete an arsenal of factors that can
damage the airway epithelium and alter cellular processes.
Secreted proteases such as alkaline protease (AprA), endotoxins
such as pyocyanin, ExoS, -T, -Y and rhamnolipids have all been
shown to modify tight junction structure leading to decreased
barrier function and contribute to the pathophysiology of CF
disease [22,23,24]. Since the Ps. aeruginosa filtrate was boiled it is
likely that its effects on the epithelium were due to heat-resistant
secretions by the bacterium. Importantly, Ps. aeruginosa filtrate
induced a greater increase in paracellular flux and reduction in RT
across CF than non-CF epithelia monolayers. This is consistent
with previous observations that tight junctions are abnormal in CF
airway epithelium and that CF epithelia display increased
paracellular permeability to both solutes and ions in the presence
of pro-inflammatory stimuli compared to normal airway cells
[13,25].
RT was also reduced by raising basolateral glucose. It is not
clear what mechanisms are involved in the response to hypergly-
caemia, but it could involve changes in AMPK activity [26], pro-
inflammatory cytokine release or glucose transporter activity [27];
all of which can modify tight junctions. In Calu-3 cells we
measured ASL glucose concentration and found this to be
increased by Ps. aeruginosa filtrate and further by elevation of
basolateral glucose concentrations. Thus, our experimental
conditions mimic the state of the airways in patients with CFRD,
where inflammation, Ps. aeruginosa infection and hyperglycaemia
could all increase paracellular permeability and drive movement of
glucose into the ASL.
Glucose is removed from ASL by apical glucose transport. We
have previously shown in human H441 airway cells that pro-
inflammatory stimuli increase GLUT2 and GLUT10 abundance
and apical glucose uptake [10]. However, this was insufficient to
prevent elevation of ASL glucose, as paracellular glucose flux
exceeded uptake. Similarly, in the current study, apical glucose
uptake was increased in both non-CF and CF epithelial cell
monolayers by exposure to Ps. aeruginosa filtrate. Interestingly,
there was no difference in the stimulated apical glucose uptake
between the two cell types, despite the much greater increase in
paracellular glucose flux across the CF monolayers. Thus, we
propose that under pro-inflammatory conditions, glucose uptake is
not sufficient to compensate the increased flux of glucose into ASL,
particularly in CF epithelial cells.
Elevation of basolateral D-glucose evoked an increase in apical
Ps. aeruginosa growth in all airway epithelial co-culture models
investigated in this study. Ps. aeruginosa utilises glucose as a growth
substrate [20] and so increased growth appears to be a direct effect
of increased availability of this nutrient. In support of this
hypothesis, increased basolateral L-glucose, which diffuses across
the tight junctions in the same way as D-glucose but is not
commonly metabolised by bacteria [28], did not stimulate the
growth of apical Ps. aeruginosa. Furthermore, the growth of Ps.
aeruginosa was greater in the lungs of hyperglycemic than of
normoglycemic mice, but there was no enhanced growth of a
mutant strain of Ps. aeruginosa (PA01) with a defect in a gene (edd)
required for catabolism of glucose [9].
Elevation of basolateral glucose from 5 to 15 mM had a greater
effect on apical growth of Ps. aeruginosa on CF compared to non-CF
monolayers. We speculate that the combination of increased
paracellular permeability in CF monolayers with an elevated
basolateral-to-apical glucose gradient further increased the avail-
ability of glucose to the bacteria, enhancing growth. In laboratory
culture we have previously shown a dose-dependent effect of
glucose, at concentrations found in airway surface liquid, on
bacterial growth [20].
Currently, there is much research into how the lack of CFTR
function in CF might affect ASL volume, composition and pH to
alter bacterial growth [4,29]. Impaired fluid secretion and
hyperabsorption in CF result in thick viscous mucus, which is
also thought to promote bacterial growth. Consistent with this
notion, we found that the presence of a thick layer of mucus in
Calu-3 cells increased the growth of Ps. aeruginosa. In Calu-3 cells,
we found that forskolin (a cAMP agonist and activator of CFTR)
increased fluid secretion, elevated pH and reduced bacterial
growth. The CFTR pore blocker (GlyH-101) inhibited forskolin-
induced fluid secretion, but did not reduce the forskolin-induced
ASL alkalinisation. Under these circumstances bacterial growth
was partially restored, but not to levels observed under control
conditions. This indicates that forskolin stimulates both CFTR-
dependent and -independent effects on bacterial growth. The
forskolin-induced CFTR-dependent inhibition of Ps. aeruginosa
growth was associated with increased ASL fluid volume. Interest-
ingly, in support of this finding, reduced CFTR expression and
depletion of ASL fluid volume has been proposed to produce a
more suitable environment for Ps. aeruginosa colonisation in the
lung [30,31]. The forskolin-induced elevation of ASL pH was
CFTR-independent. These findings are consistent with previous
studies of Calu-3 fluid secretions, which identified the anion
exchanger pendrin (also activated by elevation of cAMP), and not
CFTR, as a key mediator of bicarbonate secretion from these cells
[17]. Our data show that elevation of ASL pH was associated with
Figure 7. Basolateral glucose alters airway epithelial monolay-
er transepithelial resistance. Transepithelial resistance (RT) across
untreated Calu-3 monolayers and Calu-3 monolayers co-cultured for
7 hours with 16106 or 16108 CFU of Ps. aeruginosa (Ps. a). n = 6 in each
group, obtained from 3 independent experiments. * p,0.05.
doi:10.1371/journal.pone.0076283.g007
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decreased bacterial growth and elevated ASL pH is known to
increase the activity of pH-sensitive antimicrobials [4].
Crucially, even in the context of these well-recognised CF-
related abnormalities, elevation of basolateral glucose had a
marked additional stimulatory effect on bacterial growth. In
people with CF, the development of diabetes is associated with
accelerated pulmonary decline, increased risk of infection with
multiple antibiotic-resistant Ps. aeruginosa [5] and increased
pulmonary exacerbations [32]. These data provide evidence that
increased glucose leak into ASL as a consequence of rising blood
glucose and worsening lung inflammation could provide an
additional stimulus respiratory infection and augment the effects
of other CF-related abnormalities.
Conclusions
We have shown that elevation of basolateral glucose promotes
the apical growth of Ps. aeruginosa on CF airway epithelial
monolayers more than non-CF monolayers. Ps. aeruginosa secre-
tions induced an elevated glucose leak across CF airway epithelial
monolayers compared to non-CF monolayers which we propose
increases ASL glucose availability for bacterial growth. In
addition, elevating basolateral glucose increased Ps. aeruginosa
growth over and above the effects of CFTR-dependent fluid
secretions and mucus in Calu-3 epithelial-bacterial co-cultures.
Together these studies highlight the potential importance of
glucose in promoting Ps. aeruginosa growth and respiratory infection
in CF and CF-related diabetes and identify potential new targets
for the prevention and treatment of CF pulmonary infection.
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